Role of D2 receptor (-141 C Ins/Del) genetic polymorphism on olanzapine-induced adverse drug reaction in schizophrenic patients
Olanzapine is commonly prescribed for the management of schizophrenia and is associated with many adverse effects like weight gain, hyperglycemia, and hyperprolactinemia, which may increase the risk of other diseases like diabetes mellitus and cardiovascular diseases. Genetic polymorphism of the D2...
Saved in:
Main Authors: | Zahra Jawd Mohammed Ali (Author), Atheer Majid Rashid Al-juhiashi (Author) |
---|---|
Format: | Book |
Published: |
Pensoft Publishers,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association study between D2 receptor A-241G, rs1799978 genetic variation and olanzapine efficacy in Iraqi schizophrenic patients
by: Zahra Jawd Mohammed Ali Al-Musawi, et al.
Published: (2024) -
Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
by: Paula Soria-Chacartegui, et al.
Published: (2021) -
Olanzapine-induced Metabolic Syndrome and its Association with -759C>T Polymorphism of the HTR2C Gene in Iraqi Schizophrenic Patients
by: Zinah Abdulhameed Alobaidi, et al.
Published: (2024) -
Serum immunoglobulin levels in male schizophrenic patients before and after olanzapine therapy
by: Mahmoud Khudhayer Oglah Hussein
Published: (2011) -
Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
by: Diane Merino, et al.
Published: (2022)